No results for ‘’
JHS Svendgaard Laboratories Ltd
₹7.99
(2.20%)
Mon, 22 Jun 2026, 08:48 pm
Consumer Non-Durables
Household/Personal Care
24.5KJHS Svendgaard Laboratories Debt to Equity Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 5.94 | 14.28 | 214.33 | 9.48 | 8.35 | 62.23 | 0 | 0 | 0 | 0 | 10.61 | 12.51 | 0 | 0 | 102.62 | 0 | 0 | 0 | 0 |
| Price to book ratio | 0 | 0.69 | 0.89 | 0.28 | 1.04 | 1.24 | 0.62 | 0.40 | 0.24 | 0.15 | 0.84 | 1.29 | 1.87 | 0.95 | 0.26 | 0.68 | 0.72 | 0.71 | 0.76 | 0.55 |
| Price to sales ratio | 0 | 0.82 | 1.39 | 0.60 | 1.12 | 0.82 | 0.54 | 0.71 | 0.42 | 0.33 | 0.59 | 2.21 | 2.33 | 1.36 | 0.33 | 1.22 | 1.54 | 1.45 | 1.81 | 1.01 |
| Price to cash flow ratio | 0 | 0 | 11.73 | 0 | 0 | 0 | 0 | 0.92 | 1.05 | 2.67 | 0 | 0 | 23.13 | 0 | 4.96 | 10.49 | 0 | 5.08 | 0 | 0 |
| Enterprise value | 0 | 31.45Cr | 74.77Cr | 63.2Cr | 117Cr | 152Cr | 134Cr | 138Cr | 111Cr | 50.21Cr | 57.48Cr | 228Cr | 305Cr | 173Cr | 53.78Cr | 116Cr | 139Cr | 87.09Cr | 123Cr | 79.8Cr |
| Enterprise value to EBITDA ratio | 0 | 5.56 | 9.18 | 8.21 | 7.34 | 6.58 | 7.32 | 42.59 | 0 | 0 | 8.39 | 19.44 | 21.86 | 245.08 | 29 | 17.52 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0.56 | 0.17 | 0.56 | 0.81 | 0.56 | 0.58 | 0.58 | 1.15 | 1.59 | 0.28 | 0.03 | 0.02 | 0.01 | 0.04 | 0.05 | 0.04 | 0.03 | 0.01 | 0.03 | 0.04 |
| Return on equity % | 0 | 13.17 | 6.36 | 2.41 | 12.03 | 15.86 | 1.11 | -3.69 | -38.13 | -24.44 | -19.66 | 18.67 | 16.95 | -0.39 | -1.12 | 0.65 | -2.16 | -9.74 | -2.36 | -11.53 |
JHS Svendgaard Laboratories Ltd Debt to Equity Ratio
The JHS Svendgaard Laboratories Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate JHS Svendgaard Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the JHS Svendgaard Laboratories Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
JHS Svendgaard Laboratories Ltd (NSE: JHS, BSE: 532771) is currently trading at ₹7.99, with a market capitalization of ₹69.57Cr. As a leading company in the Consumer non-durables sector and Household/Personal care industry, monitoring the JHS Svendgaard Laboratories Ltd Debt to Equity Ratio is essential for fundamental analysis.
JHS Svendgaard Laboratories Ltd Debt to Equity Ratio Current Value
The current JHS Svendgaard Laboratories Ltd Debt to Equity Ratio stands at 0.04.
The latest JHS Svendgaard Laboratories Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
JHS Svendgaard Laboratories Ltd Debt to Equity Ratio Historical Trend
The JHS Svendgaard Laboratories Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.04
- 2023: 0.03
- 2022: 0.01
- 2021: 0.03
- 2020: 0.04
The recent rise in JHS Svendgaard Laboratories Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.
What JHS Svendgaard Laboratories Ltd Debt to Equity Ratio Indicates for Investors
The JHS Svendgaard Laboratories Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
JHS Svendgaard Laboratories Ltd Debt to Equity Ratio Analysis Summary
The JHS Svendgaard Laboratories Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking JHS Svendgaard Laboratories Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of JHS Svendgaard Laboratories Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.